| 臺大學術典藏 |
2020-02-06T05:22:02Z |
Cell-type-dependent associations of heme oxygenase-1 GT-repeat polymorphisms with the cancer risk in arsenic-exposed individuals: A preliminary report
|
Lee T.C.;Chiou H.-Y.;Chen C.-J.;Hsu L.-I.;WEN-FANG CHENG;Wu M.M.; Wu M.M.; WEN-FANG CHENG; Hsu L.-I.; Chen C.-J.; Chiou H.-Y.; Lee T.C.; Wu M.M.; WEN-FANG CHENG; Hsu L.-I.; Chen C.-J.; Chiou H.-Y.; Lee T.C. |
| 臺大學術典藏 |
2020-02-06T05:22:02Z |
Circulating IGF system and treatment outcome in epithelial ovarian cancer
|
Chou C.-Y.;Hsu K.-F.;Cheng Y.-M.;Wu Y.-P.;WEN-FANG CHENG;Huang Y.-F.; Huang Y.-F.; WEN-FANG CHENG; Wu Y.-P.; Cheng Y.-M.; Hsu K.-F.; Chou C.-Y.; Huang Y.-F.; WEN-FANG CHENG; Wu Y.-P.; Cheng Y.-M.; Hsu K.-F.; Chou C.-Y. |
| 臺大學術典藏 |
2020-02-06T05:22:02Z |
Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan
|
Lin M.-C.; You S.-L.; WEN-FANG CHENG; Lai M.-S.; Hsu T.-H.; Chiang C.-J.; Chen C.-A.; Chiang Y.-C.; Lai M.-S.; WEN-FANG CHENG; You S.-L.; Lin M.-C.; Hsu T.-H.; Chiang C.-J.; Lai M.-S.;WEN-FANG CHENG;You S.-L.;Lin M.-C.;Hsu T.-H.;Chiang C.-J.;Chen C.-A.;Chiang Y.-C.; Chiang Y.-C.; Chen C.-A. |
| 臺大學術典藏 |
2020-02-06T05:22:01Z |
Solitary primary peritoneal carcinoma arising from the omentum
|
WEN-FANG CHENG;Chen C.-A.;Wu C.-J.;Lin M.-C.;Tai Y.-J.; Tai Y.-J.; Lin M.-C.; Wu C.-J.; Chen C.-A.; WEN-FANG CHENG; Tai Y.-J.; Lin M.-C.; Wu C.-J.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:59Z |
Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas
|
WEN-FANG CHENG;Chou C.-Y.;Cheng Y.-Y.K.;You S.-L.;Hu Y.-H.;Chang M.-C.;Chiang Y.-C.;Chen C.-A.; Chen C.-A.; Chiang Y.-C.; Chang M.-C.; Hu Y.-H.; You S.-L.; Cheng Y.-Y.K.; Chou C.-Y.; WEN-FANG CHENG; Chen C.-A.; Chiang Y.-C.; Chang M.-C.; Hu Y.-H.; You S.-L.; Cheng Y.-Y.K.; Chou C.-Y.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:59Z |
Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma
|
WEN-FANG CHENG;Chen C.-A.;Hsieh S.-F.;Chen T.-C.;Fu C.-F.;Chang M.-C.;Chang C.-F.;Lin H.-W.;Chiang Y.-C.; Chiang Y.-C.; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG; Chiang Y.-C.; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:59Z |
Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFN�^
|
Roden R.B.S.; Wu T.-C.; Trimble C.L.; Hung C.-F.; Soong R.-S.; Song L.; Trieu J.; Knoff J.; He L.; Tsai Y.-C.; Huh W.; Chang Y.-N.; WEN-FANG CHENG; Roden R.B.S.; Wu T.-C.; Trimble C.L.; Hung C.-F.; Hung C.-F.;Trimble C.L.;Wu T.-C.;Roden R.B.S.;WEN-FANG CHENG;Chang Y.-N.;Huh W.;Tsai Y.-C.;He L.;Knoff J.;Trieu J.;Song L.;Soong R.-S.; Soong R.-S.; Song L.; Trieu J.; Knoff J.; He L.; Tsai Y.-C.; Huh W.; Chang Y.-N.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:58Z |
Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients
|
WEN-FANG CHENG;Chen C.-A.;Kuo K.-T.;Huang H.-D.;Tang Y.-C.;Huang C.-T.;Huang W.-Y.;Chang M.-C.;Huang C.-Y.; Huang C.-Y.; Chang M.-C.; Huang W.-Y.; Huang C.-T.; Tang Y.-C.; Huang H.-D.; Kuo K.-T.; Chen C.-A.; WEN-FANG CHENG; Huang C.-Y.; Chang M.-C.; Huang W.-Y.; Huang C.-T.; Tang Y.-C.; Huang H.-D.; Kuo K.-T.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:58Z |
Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation
|
WEN-FANG CHENG;Chen C.-A.;Chen T.-C.;Chen Y.-L.;Chang M.-C.;Huang C.-T.; Huang C.-T.; Chang M.-C.; Chen Y.-L.; Chen T.-C.; Chen C.-A.; WEN-FANG CHENG; Huang C.-T.; Chang M.-C.; Chen Y.-L.; Chen T.-C.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:58Z |
Molecular alterations in endometrial and ovarian clear cell carcinomas: Clinical impacts of telomerase reverse transcriptase promoter mutation
|
Kuo K.-T.;Lin M.-C.;Chen C.-A.;WEN-FANG CHENG;Chiang Y.-C.;Huang H.-N.; Huang H.-N.; Chiang Y.-C.; WEN-FANG CHENG; Chen C.-A.; Lin M.-C.; Kuo K.-T.; Huang H.-N.; Chiang Y.-C.; WEN-FANG CHENG; Chen C.-A.; Lin M.-C.; Kuo K.-T. |
| 臺大學術典藏 |
2020-02-06T05:21:58Z |
IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
|
WEN-FANG CHENG;Chen C.-A.;Hsieh S.-F.;Huang C.-T.;Lin H.-W.;Chang M.-C.;Chou C.-Y.;Chen Y.-L.; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:56Z |
Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis
|
WEN-FANG CHENG;Chang S.-F.;Huang S.-H.;Hsiao C.-C.;Shih D.T.-B.;Ho C.-M.; Ho C.-M.; Shih D.T.-B.; Hsiao C.-C.; Huang S.-H.; Chang S.-F.; WEN-FANG CHENG; Ho C.-M.; Shih D.T.-B.; Hsiao C.-C.; Huang S.-H.; Chang S.-F.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:56Z |
Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway
|
WEN-FANG CHENG;Chang S.-F.;Huang S.-H.;Huang C.-J.;Ho C.-M.; Ho C.-M.; Huang C.-J.; Huang S.-H.; Chang S.-F.; WEN-FANG CHENG; Ho C.-M.; Huang C.-J.; Huang S.-H.; Chang S.-F.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:56Z |
The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia
|
Lai M.-S.;Yang J.C.H.;Cheng A.-L.;WEN-FANG CHENG;Hsu C.;Shao Y.-Y.;Yang Y.-Y.;Lai C.-L.;Shau W.-Y.;Kuo R.;Lin Z.-Z.;Kuo H.-Y.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S. |
| 臺大學術典藏 |
2020-02-06T05:21:56Z |
Establishment of a New Ovarian Cancer Cell Line CA5171
|
Chen C.-A.;Hsieh C.-Y.;Lin H.-P.;Kuo K.-T.;Lu T.-P.;Chang M.-C.;WEN-FANG CHENG;Chiang Y.-C.; Chiang Y.-C.; WEN-FANG CHENG; Chang M.-C.; Lu T.-P.; Kuo K.-T.; Lin H.-P.; Hsieh C.-Y.; Chen C.-A.; Chiang Y.-C.; WEN-FANG CHENG; Chang M.-C.; Lu T.-P.; Kuo K.-T.; Lin H.-P.; Hsieh C.-Y.; Chen C.-A. |
| 臺大學術典藏 |
2020-02-06T05:21:55Z |
Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine
|
Chen Y.-L.; Chiang Y.-C.; Cheng Y.-J.; Jen Y.-W.; Chen C.-A.; WEN-FANG CHENG; Sun W.-Z.; Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Cheng Y.-J.; Jen Y.-W.; Chen C.-A.; WEN-FANG CHENG; Sun W.-Z.; Sun W.-Z.;WEN-FANG CHENG;Chen C.-A.;Jen Y.-W.;Cheng Y.-J.;Chiang Y.-C.;Chen Y.-L.;Chang M.-C.; Chang M.-C. |
| 臺大學術典藏 |
2020-02-06T05:21:55Z |
Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator
|
WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Tang Y.-C.;Chen T.-C.;Chiang Y.-C.;Chen Y.-L.;Chang M.-C.; Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Chen T.-C.; Tang Y.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chang M.-C.; Chen Y.-L.; Chiang Y.-C.; Chen T.-C.; Tang Y.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:54Z |
Metronomic chemotherapy and immunotherapy in cancer treatment
|
WEN-FANG CHENG; WEN-FANG CHENG;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C. |
| 臺大學術典藏 |
2020-02-06T05:21:54Z |
Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study
|
Taiwan Cervical Cancer Prevention Surveillance Center;Chen C.-A.;Lai M.-S.;WEN-FANG CHENG;You S.-L.;Chiang C.-J.;Hsieh S.-F.;Chen Y.-Y.;Chiang Y.-C.; Chiang Y.-C.; Chen Y.-Y.; Hsieh S.-F.; Chiang C.-J.; You S.-L.; WEN-FANG CHENG; Lai M.-S.; Chen C.-A.; Taiwan Cervical Cancer Prevention Surveillance Center; Chiang Y.-C.; Chen Y.-Y.; Hsieh S.-F.; Chiang C.-J.; You S.-L.; WEN-FANG CHENG; Lai M.-S.; Chen C.-A.; Taiwan Cervical Cancer Prevention Surveillance Center |
| 臺大學術典藏 |
2020-02-06T05:21:53Z |
Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies
|
Chen Y.-Y.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; WEN-FANG CHENG;Chen C.-A.;Chen Y.-L.;Chiang Y.-C.;Chen Y.-Y.;Lee S.-P.;Hsu H.-C.;Tai Y.-J.;Tai Y.-H.; Tai Y.-H.; Tai Y.-J.; Hsu H.-C.; Lee S.-P.; Chen Y.-Y.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Tai Y.-H.; Tai Y.-J.; Hsu H.-C.; Lee S.-P. |
| 臺大學術典藏 |
2020-02-06T05:21:52Z |
Clinical management and risk reduction in women with low-grade squamous intraepithelial lesion cytology: A population-based cohort study
|
Taiwan Cervical Cancer Control Task Force;WEN-FANG CHENG;Chen C.-A.;Chen H.-C.;You S.-L.;Chiang C.-J.;Hsu H.-C.;Chen Y.-Y.;Tai Y.-J.; Tai Y.-J.; Chen Y.-Y.; Hsu H.-C.; Chiang C.-J.; You S.-L.; Chen H.-C.; Chen C.-A.; WEN-FANG CHENG; Taiwan Cervical Cancer Control Task Force; Tai Y.-J.; Chen Y.-Y.; Hsu H.-C.; Chiang C.-J.; You S.-L.; Chen H.-C.; Chen C.-A.; WEN-FANG CHENG; Taiwan Cervical Cancer Control Task Force |
| 臺大學術典藏 |
2020-02-06T05:21:51Z |
Large cell neuroendocrine carcinoma of the endometrium: A case report and literature review
|
Lin M.-C.; Chen C.-A.; WEN-FANG CHENG; WEN-FANG CHENG;Chen C.-A.;Lin M.-C.;Chen Y.-L.;Tu Y.-A.; Tu Y.-A.; Chen Y.-L.; Lin M.-C.; Chen C.-A.; WEN-FANG CHENG; Tu Y.-A.; Chen Y.-L. |
| 臺大學術典藏 |
2020-02-06T05:21:51Z |
Health effects of a forest environment on natural killer cells in humans: An observational pilot study
|
Tsao T.-M.; Tsai M.-J.; Hwang J.-S.; WEN-FANG CHENG; Wu C.-F.; Chou C.-C.; Su T.-C.; Tsao T.-M.; Tsai M.-J.; Hwang J.-S.; WEN-FANG CHENG; Wu C.-F.; Chou C.-C.; Su T.-C.; Su T.-C.;Chou C.-C.;Wu C.-F.;WEN-FANG CHENG;Hwang J.-S.;Tsai M.-J.;Tsao T.-M. |
| 臺大學術典藏 |
2020-02-06T05:21:51Z |
Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
|
WEN-FANG CHENG;Tang C.-H.;Hsieh S.-F.;You S.-L.;Chen Y.-Y.;Chiang C.-J.;Chen C.-A.; Chen C.-A.; Chiang C.-J.; Chen Y.-Y.; You S.-L.; Hsieh S.-F.; Tang C.-H.; WEN-FANG CHENG; Chen C.-A.; Chiang C.-J.; Chen Y.-Y.; You S.-L.; Hsieh S.-F.; Tang C.-H.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:50Z |
Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: A population-based cohort study
|
WEN-FANG CHENG;Chen C.-A.;You S.-L.;Chiang C.-J.;Hsu H.-C.;Chen Y.-Y.;Tai Y.-J.; Tai Y.-J.; Chen Y.-Y.; Hsu H.-C.; Chiang C.-J.; You S.-L.; Chen C.-A.; WEN-FANG CHENG; Tai Y.-J.; Chen Y.-Y.; Hsu H.-C.; Chiang C.-J.; You S.-L.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:50Z |
Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation
|
WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Sun N.-Y.;Lin H.-W.;Chiang Y.-C.;Chang M.-C.;Chen Y.-L.; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Chang M.-C.; Chiang Y.-C.; Lin H.-W.; Sun N.-Y.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:50Z |
Torsion of pedunculated subserous uterine leiomyoma: A rare complication of a common disease
|
WEN-FANG CHENG;Chen C.-A.;Chen Y.-L.;Lai Y.-L.; Lai Y.-L.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Lai Y.-L.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:50Z |
Prognostic factors in epithelial ovarian cancer: A population-based study
|
WEN-FANG CHENG;Wu F.-L.L.;Shen L.-J.;Lai M.-S.;Huang C.-F.;Chang L.-C.; Chang L.-C.; Huang C.-F.; Lai M.-S.; Shen L.-J.; Wu F.-L.L.; WEN-FANG CHENG; Chang L.-C.; Huang C.-F.; Lai M.-S.; Shen L.-J.; Wu F.-L.L.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:49Z |
Factors predicting parametrial invasion in patients with early-stage cervical carcinomas
|
WEN-FANG CHENG; Chiang Y.-C.; Chen C.-A.; Chen Y.-L.; Tai Y.-J.; Hsu H.-C.; WEN-FANG CHENG; Chen C.-A.; Chiang Y.-C.; Chen Y.-L.; Tai Y.-J.; Hsu H.-C.; WEN-FANG CHENG;Chen C.-A.;Chiang Y.-C.;Chen Y.-L.;Tai Y.-J.;Hsu H.-C. |
| 臺大學術典藏 |
2020-02-06T05:21:49Z |
Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: A Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study
|
Yen M.-S.;Hsiao S.-M.;Kan Y.-Y.;Kang C.-Y.;Huang C.-Y.;Chang Y.-Y.;Chen Y.-C.;Ke Y.-M.;Chiang A.-J.;WEN-FANG CHENG;Hsu K.-F.;Chen M.-Y.;Chen J.-R.;Fu H.-C.; Fu H.-C.; Chen J.-R.; Chen M.-Y.; Hsu K.-F.; WEN-FANG CHENG; Chiang A.-J.; Ke Y.-M.; Chen Y.-C.; Chang Y.-Y.; Huang C.-Y.; Kang C.-Y.; Kan Y.-Y.; Hsiao S.-M.; Yen M.-S.; Fu H.-C.; Chen J.-R.; Chen M.-Y.; Hsu K.-F.; WEN-FANG CHENG; Chiang A.-J.; Ke Y.-M.; Chen Y.-C.; Chang Y.-Y.; Huang C.-Y.; Kang C.-Y.; Kan Y.-Y.; Hsiao S.-M.; Yen M.-S. |
| 臺大學術典藏 |
2020-02-06T05:21:49Z |
Vitamin D�Vbinding protein enhances epithelial ovarian cancer progression by regulating the insulin-like growth factor-1/akt pathway and Vitamin D receptor transcription
|
Chou C.-Y.;Shen W.-L.;Peng S.-L.;WEN-FANG CHENG;Wu Y.-H.;Huang Y.-F.; Huang Y.-F.; Wu Y.-H.; WEN-FANG CHENG; Peng S.-L.; Shen W.-L.; Chou C.-Y.; Huang Y.-F.; Wu Y.-H.; WEN-FANG CHENG; Peng S.-L.; Shen W.-L.; Chou C.-Y. |
| 臺大學術典藏 |
2020-02-06T05:21:48Z |
Cost-effectiveness analysis of human papillomavirus vaccination in adolescent girls in Taiwan
|
Lee C.;Van Kriekinge G.;Mukherjee P.;Hsieh J.-Y.;Huang L.-W.;You S.L.;Jiang J.-H.;WEN-FANG CHENG;Tang C.-H.; Tang C.-H.; WEN-FANG CHENG; Jiang J.-H.; You S.L.; Huang L.-W.; Hsieh J.-Y.; Mukherjee P.; Van Kriekinge G.; Lee C.; Tang C.-H.; WEN-FANG CHENG; Jiang J.-H.; You S.L.; Huang L.-W.; Hsieh J.-Y.; Mukherjee P.; Van Kriekinge G.; Lee C. |
| 臺大學術典藏 |
2020-02-06T05:21:48Z |
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
|
WEN-FANG CHENG;Chen C.-A.;Chiang Y.-C.;Lin H.-P.;Lu T.-P.;Chang M.-C.;Fu C.-F.;Lin H.-W.; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:48Z |
CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells
|
WEN-FANG CHENG;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chen Y.-L.;Sun N.-Y.;Chiang Y.-C.;Lin H.-W.; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Chiang Y.-C.; Sun N.-Y.; Chen Y.-L.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:47Z |
Bevacizumab dose affects the severity of adverse events in gynecologic malignancies
|
Hsu H.-C.; Tai Y.-J.; Chen Y.-L.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG; Lee S.-P.; Hsu H.-C.; Tai Y.-J.; Chen Y.-L.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG; WEN-FANG CHENG;Chen C.-A.;Chiang Y.-C.;Chen Y.-L.;Tai Y.-J.;Hsu H.-C.;Lee S.-P.; Lee S.-P. |
| 臺大學術典藏 |
2020-02-06T05:21:46Z |
Prognostic factors of early stage epithelial ovarian carcinoma
|
WEN-FANG CHENG;Twu N.-F.;Hsu H.-C.;Wu H.-H.;Lau H.-Y.;Hsieh S.-F.; Hsieh S.-F.; Lau H.-Y.; Wu H.-H.; Hsu H.-C.; Twu N.-F.; WEN-FANG CHENG; Hsieh S.-F.; Lau H.-Y.; Wu H.-H.; Hsu H.-C.; Twu N.-F.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:46Z |
Clear cell carcinoma of the abdominal wall as a rare complication of general obstetric and gynecologic surgeries: 15 years of experience at a large academic institution
|
WEN-FANG CHENG;Chen C.-A.;Chen Y.-L.;Kuo K.-T.;Hsu H.-C.;Lai Y.-L.; Lai Y.-L.; Hsu H.-C.; Kuo K.-T.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Lai Y.-L.; Hsu H.-C.; Kuo K.-T.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:46Z |
Developing a prognostic gene panel of epithelial ovarian cancer patients by a machine learning model
|
Chen C.-A.;WEN-FANG CHENG;Chiang Y.-C.;Hu Y.-H.;Lin H.-P.;Chang M.-C.;Chen C.-H.;Kuo K.-T.;Lu T.-P.; Lu T.-P.; Kuo K.-T.; Chen C.-H.; Chang M.-C.; Lin H.-P.; Hu Y.-H.; Chiang Y.-C.; WEN-FANG CHENG; Chen C.-A.; Lu T.-P.; Kuo K.-T.; Chen C.-H.; Chang M.-C.; Lin H.-P.; Hu Y.-H.; Chiang Y.-C.; WEN-FANG CHENG; Chen C.-A. |
| 臺大學術典藏 |
2020-02-06T05:21:45Z |
Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes
|
WEN-FANG CHENG;Chien C.-L.;Sun W.-Z.;Chen C.-A.;Tai Y.-J.;Chang C.-F.;Chiang Y.-C.;Lin H.-W.;Chen Y.-L.;Sun N.-Y.; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG; Sun N.-Y.; Chen Y.-L.; Lin H.-W.; Chiang Y.-C.; Chang C.-F.; Tai Y.-J.; Chen C.-A.; Sun W.-Z.; Chien C.-L.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:43Z |
Impact of adjuvant modalities on survival in patients with advanced stage endometrial carcinoma: A retrospective analysis from a tertiary medical center
|
Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Chiang Y.-C.; Hsu H.-C.; WEN-FANG CHENG;Chen C.-A.;Chen Y.-L.;Chiang Y.-C.;Hsu H.-C.;Tai Y.-J.; Tai Y.-J.; Hsu H.-C.; Chiang Y.-C.; Chen Y.-L.; Chen C.-A.; WEN-FANG CHENG; Tai Y.-J. |
| 臺大學術典藏 |
2020-02-06T05:21:43Z |
mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment
|
WEN-FANG CHENG;Sun W.-Z.;Chen C.-A.;Hung H.-C.;Yie J.-C.;Sun N.-Y.;Lin H.-W.;Chen Y.-L.; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG; Chen Y.-L.; Lin H.-W.; Sun N.-Y.; Yie J.-C.; Hung H.-C.; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:41Z |
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes
|
WEN-FANG CHENG; Chen C.-A.; Sun W.-Z.; Lai Y.-L.; Chien C.-L.; Lin H.-W.; Chen Y.-L.; WEN-FANG CHENG; Chen C.-A.; Sun W.-Z.; WEN-FANG CHENG;Chen C.-A.;Sun W.-Z.;Lai Y.-L.;Chien C.-L.;Lin H.-W.;Chen Y.-L.; Chen Y.-L.; Lin H.-W.; Chien C.-L.; Lai Y.-L. |
| 臺大學術典藏 |
2019-09-09T00:55:36Z |
Impact of adjuvant modalities on survival in patients with advanced stage endometrial carcinoma: A retrospective analysis from a tertiary medical center
|
YING-CHENG CHIANG;Chen, Chi An;Hsu, Heng Cheng;Tai, Yi Jou;WEN-FANG CHENG;Chen, Yu Li; Chen, Yu Li; WEN-FANG CHENG; Tai, Yi Jou; Hsu, Heng Cheng; Chen, Chi An |
| 臺大學術典藏 |
2019-09-09T00:55:20Z |
mTOR inhibitors can enhance the anti-tumor effects of DNA vaccines through modulating dendritic cell function in the tumor microenvironment
|
Yie, Jr Chi; Sun, Nai Yun; WEI-ZEN SUN; Chen, Chi An;WEN-FANG CHENG;Lin, Han Wei;Hung, Hsueh Chih;Chen, Yu Li;Yie, Jr Chi;Sun, Nai Yun;WEI-ZEN SUN; Chen, Yu Li; Hung, Hsueh Chih; Lin, Han Wei; WEN-FANG CHENG; Chen, Chi An |
| 臺大學術典藏 |
2019-09-09T00:55:20Z |
Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes
|
Sun, Nai Yun;WEN-FANG CHENG;WEI-ZEN SUN;Chen, Chi An;Lin, Han Wei;CHUNG-LIANG CHIEN;Tai, Yi Jou;Chang, Chi Fang;YING-CHENG CHIANG;Chen, Yu Li; Chen, Yu Li; YING-CHENG CHIANG; Chang, Chi Fang; Tai, Yi Jou; CHUNG-LIANG CHIEN; Lin, Han Wei; Chen, Chi An; Sun, Nai Yun |
| 臺大學術典藏 |
2019-09-09T00:55:20Z |
CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells
|
YING-CHENG CHIANG;Tai, Yi Jou;Chen, Chi An;Sun, Nai Yun;Chen, Yu Li;Lin, Han Wei;Chang, Chi Fang;WEN-FANG CHENG; WEN-FANG CHENG; Chang, Chi Fang; Lin, Han Wei; Chen, Yu Li; Sun, Nai Yun; Chen, Chi An; Tai, Yi Jou; YING-CHENG CHIANG; WEN-FANG CHENG; Chang, Chi Fang; Lin, Han Wei; Chen, Yu Li; Sun, Nai Yun; Chen, Chi An |
| 臺大學術典藏 |
2019-09-09T00:55:20Z |
Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation
|
Chang, Ming Cheng; WEN-FANG CHENG; Chen, Chi An; Lin, Han Wei; Chen, Yu Li; WEI-ZEN SUN; Sun, Nai Yun; YING-CHENG CHIANG; Chen, Chi An;WEN-FANG CHENG;Chang, Ming Cheng;Chen, Yu Li;Lin, Han Wei;WEI-ZEN SUN;Sun, Nai Yun;YING-CHENG CHIANG |
| 臺大學術典藏 |
2019-07-08T03:32:43Z |
Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model
|
CHI-AN CHEN;WEN-FANG CHENG;YING-CHENG CHIANG;Hu, Yu-Hao;Lin, Hsiu-Ping;Chang, Ming-Cheng;Chen, Ching-Hsuan;KUAN-TING KUO;TZU-PIN LU; T.-P. LU; KUAN-TING KUO; Chen, Ching-Hsuan; Chang, Ming-Cheng; Lin, Hsiu-Ping; Hu, Yu-Hao; YING-CHENG CHIANG; WEN-FANG CHENG; CHI-AN CHEN |
| 臺大學術典藏 |
2019-02-20T06:38:36Z |
Factors predicting parametrial invasion in patients with early-stage cervical carcinomas
|
Hsu, Heng-Cheng;WEN-FANG CHENG;CHI-AN CHEN;YING-CHENG CHIANG;Chen, Yu-Li;Tai, Yi-Jou; Hsu, Heng-Cheng; Tai, Yi-Jou; Chen, Yu-Li; YING-CHENG CHIANG; CHI-AN CHEN; WEN-FANG CHENG |
| 臺大學術典藏 |
2019-02-20T06:37:22Z |
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
|
Lin, Hsiu-Ping;Chang, Ming-Cheng;Fu, Chi-Feng;Wen-Fang Cheng;Chi-An Chen;Ying-Cheng Chiang;Tzu-Pin Lu;Lin, Han-Wei; Lin, Han-Wei; Fu, Chi-Feng; Chang, Ming-Cheng; TZU-PIN LU; Lin, Hsiu-Ping; YING-CHENG CHIANG; CHI-AN CHEN; WEN-FANG CHENG |
